Farther Finance Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.57M Buy
13,098
+3,194
+32% +$1.53M 0.05% 321
2026
Q1
$4.9M Buy
9,904
+362
+4% +$196K 0.05% 355
2025
Q4
$5.53M Buy
9,542
+1,854
+24% +$1.05M 0.06% 284
2025
Q3
$3.73M Buy
7,688
+1,144
+17% +$532K 0.06% 287
2025
Q2
$2.65M Buy
6,544
+1,496
+30% +$625K 0.05% 297
2025
Q1
$2.44M Buy
5,048
+1,100
+28% +$596K 0.06% 259
2024
Q4
$2.05M Buy
3,948
+124
+3% +$68.2K 0.07% 220
2024
Q3
$2.37M Buy
3,824
+539
+16% +$319K 0.09% 184
2024
Q2
$1.78M Buy
3,285
+1,051
+47% +$602K 0.09% 185
2024
Q1
$1.29M Buy
2,234
+509
+30% +$286K 0.08% 210
2023
Q4
$916K Buy
1,725
+530
+44% +$257K 0.07% 249
2023
Q3
$605K Buy
1,195
+39
+3% +$20.8K 0.1% 179
2023
Q2
$603K Buy
1,156
+254
+28% +$137K 0.13% 142
2023
Q1
$520K Buy
902
+632
+234% +$356K 0.15% 126
2022
Q4
$149K Buy
+270
New +$143K 0.06% 261

Other funds holding TMO

Farther Finance Advisors's TMO Position: Q2 2026 in Review

Farther Finance Advisors increased its Thermo Fisher Scientific (TMO) stake by 32% in Q2 2026, buying an estimated $1.53M and bringing the position to 13,098 shares worth $6.57M. The position accounts for 0.05% of the portfolio, ranked #321.

Farther Finance Advisors first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Farther Finance Advisors held 13,098 shares of Thermo Fisher Scientific worth $6.57M as of Q2 2026.
  • Farther Finance Advisors bought 3,194 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.53M.
  • Thermo Fisher Scientific made up 0.05% of Farther Finance Advisors's portfolio in Q2 2026, its #321 holding.
  • Farther Finance Advisors first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.